Bigul

ANUH PHARMA LTD. - 506260 - Board Meeting Intimation for Prior Intimation Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

ANUH PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2022 ,inter alia, to consider and approve Pursuant to the provisions of Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on Friday, 4th February, 2022, inter alia: 1)To consider and approve Unaudited Financial Results of the Company for the quarter and nine months ended 31st December, 2021; 2)To consider and appoint Mr. Bharat Gangani for the post of Company Secretary & Compliance Officer of the Company; and 3)To consider any other matter with the permission of the Chairman.
25-01-2022
Bigul

ANUH PHARMA LTD. - 506260 - Board Meeting Outcome for Outcome Of Board Meeting

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors of the Company (the "Board") at its Performance Evaluation Meeting held today i.e. Friday, 21st January, 2022, has noted the resignation of Ms. Ashwini Ambrale, from the post of Company Secretary and Compliance Officer of the Company.
21-01-2022
Bigul

ANUH PHARMA LTD. - 506260 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Ms. Ashwini Ambrale, has tendered her resignation on 13th January, 2022 from the post of Company Secretary and Compliance Officer of the Company due to personal reasons. The Company has accepted her resignation and relived her with effect from the closing of business hours of Thursday, 13th January, 2022. Her successor shall be appointed shortly and the same shall be intimated to the Stock Exchange in due course.
13-01-2022
Bigul

ANUH PHARMA LTD. - 506260 - Shareholding for the Period Ended December 31, 2021

Anuh Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click here
06-01-2022
Bigul

ANUH PHARMA LTD. - 506260 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Pursuant to the provisions of Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants), Regulations, 2018, please find attached herewith the copy of the certificate issued by M/s Bigshare Services Pvt. Ltd., the Registrar and Share Transfer Agent of the Company for the quarter ended 31st December, 2021.
06-01-2022
Bigul

ANUH PHARMA LTD. - 506260 - Statement Of Investor Complaints For The Quarter Ended December 2021

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Ashwini AmbraleDesignation :- Company Secretary and Compliance Officer
06-01-2022
Bigul

ANUH PHARMA LTD. - 506260 - Closure of Trading Window

Pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and in compliance with the Company's Code of Conduct for prevention of Insider Trading, the Trading window for dealing in the securities of the Company will be closed for the Designated Persons and their immediate relatives, from Friday, December 31, 2021 till 48 hours after the declaration of Unaudited Financial Results of the Company for the quarter & nine months ended December 31, 2021.
24-12-2021
Bigul

ANUH PHARMA LTD. - 506260 - Announcement under Regulation 30 (LODR)-Demise

Please find attached herewith the intimation of Death of Smt. Damyanti N. Shah, belonging to the Promoter Group of the Company
08-12-2021
Bigul

ANUH PHARMA LTD. - 506260 - Submission Of Disclosure Of Related Party Transactions For The Half Year Ended September 30, 2021

Pursuant to the provisions of 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the disclosure of related party transactions on a consolidated basis for the half year ended September 30, 2021.
20-11-2021
Bigul

ANUH PHARMA LTD. - 506260 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

We are submitting herewith the Transcript of Earnings Audio Conference Call held on 16th November, 2021 at 4.00 PM wherein Financial Performance for Quarter ended 30th September, 2021 was discussed.
18-11-2021
Next Page
Close

Let's Open Free Demat Account